Amos Panet

From Wikipedia, the free encyclopedia

Amos Panet is a distinguished Professor of Virology at the Hebrew University of Jerusalem.[1][2][3] His research has focused on virology and biotechnology.[1][4]

Career[edit]

Panet has been associated with the Hebrew University of Jerusalem since 1982.[2][5] During his tenure, he served as the chief scientist and director of at Bio-Technology General Corp, an Israeli biotechnology company.[5]

He co-founded Medgenix, a biotech company focused on creating a novel biopump.[5][6] Another venture initiated by Panet was Theravir, which focused on developing an oncolytic virus for cancer therapy.[7][8]

Selected publications[edit]

  • Modeling of human cytomegalovirus maternal-fetal transmission in a novel decidual organ culture.[9]
  • Innate defense mechanisms against HSV-1 infection in the target tissues, skin and brain.[10]
  • Ex vivo transduction of human dermal tissue structures for autologous implantation production and delivery of therapeutic proteins.[11]
  • Human Nasal and Lung Tissues Infected Ex Vivo with SARS-CoV-2 Provide Insights into Differential Tissue-Specific and Virus-Specific Innate Immune Responses in the Upper and Lower Respiratory Tract.[12]

References[edit]

  1. ^ a b "Prof. Amos Panet". medicine.ekmd.huji.ac.il. Retrieved 2024-05-05.
  2. ^ a b "Something went wrong..." en.huji.ac.il. Retrieved 2024-05-05.
  3. ^ "Prof. Amos Panet". BFHU. Retrieved 2024-05-05.
  4. ^ Index, AD Scientific. "Amos Panet - AD Scientific Index 2024". www.adscientificindex.com. Retrieved 2024-05-05.
  5. ^ a b c "Amos Panet".
  6. ^ "Coronavirus: How Easy Will It Be to Develop Drugs and Vaccines". BFHU. Retrieved 2024-05-05.
  7. ^ "Viruses: The new cancer hunters". IsraCast. 2006-02-28. Retrieved 2024-05-05.
  8. ^ "Amos Panet Inventions, Patents and Patent Applications - Justia Patents Search". patents.justia.com. Retrieved 2024-05-05.
  9. ^ Weisblum, Yiska; Panet, Amos; Zakay-Rones, Zichria; Haimov-Kochman, Ronit; Goldman-Wohl, Debra; Ariel, Ilana; Falk, Haya; Natanson-Yaron, Shira; Goldberg, Miri D.; Gilad, Ronit; Lurain, Nell S.; Greenfield, Caryn; Yagel, Simcha; Wolf, Dana G. (2011-12-15). "Modeling of Human Cytomegalovirus Maternal-Fetal Transmission in a Novel Decidual Organ Culture". Journal of Virology. 85 (24): 13204–13213. doi:10.1128/JVI.05749-11. ISSN 0022-538X. PMC 3233115. PMID 21976654.
  10. ^ Tsalenchuck, Yael; Steiner, Israel; Panet, Amos (2016-10-01). "Innate defense mechanisms against HSV-1 infection in the target tissues, skin and brain". Journal of NeuroVirology. 22 (5): 641–649. doi:10.1007/s13365-016-0440-9. ISSN 1355-0284.
  11. ^ Brill-Almon, Einat; Stern, Baruch; Afik, Daniel; Kaye, Joel; Langer, Noga; Bellomo, Stephen; Shavit, Moni; Pearlman, Andrew; Lippin, Yitzhak; Panet, Amos; Shani, Noam (2005-08-01). "Ex vivo transduction of human dermal tissue structures for autologous implantation production and delivery of therapeutic proteins". Molecular Therapy. 12 (2): 274–282. doi:10.1016/j.ymthe.2005.03.023.
  12. ^ Alfi, Or; Yakirevitch, Arkadi; Wald, Ori; Wandel, Ori; Izhar, Uzi; Oiknine-Djian, Esther; Nevo, Yuval; Elgavish, Sharona; Dagan, Elad; Madgar, Ory; Feinmesser, Gilad; Pikarsky, Eli; Bronstein, Michal; Vorontsov, Olesya; Jonas, Wayne (2021-06-24). Heise, Mark T. (ed.). "Human Nasal and Lung Tissues Infected Ex Vivo with SARS-CoV-2 Provide Insights into Differential Tissue-Specific and Virus-Specific Innate Immune Responses in the Upper and Lower Respiratory Tract". Journal of Virology. 95 (14). doi:10.1128/JVI.00130-21. ISSN 0022-538X. PMC 8223920. PMID 33893170.